Trump Bans Microsoft Foreign Worker Visas
The White House has moved to bar Microsoft from sponsoring foreign nationals for U.S. work visas, marking an escalation in immigration enfor...
Status Summary: Contextual analysis of live event stream.
Pfizer announced a $43 billion cash deal to buy oncology specialist Seagen.
Resolution: The acquisition cleared U.S. and EU antitrust reviews and closed in early 2024, expanding Pfizer's cancer portfolio.
Merck disclosed a $11.5 billion purchase of rare‑disease biotech Acceleron Pharma.
Resolution: Regulators approved the deal after concessions on pipeline sharing, bolstering Merck’s specialty‑medicine pipeline.
Novartis announced a $2.7 billion acquisition of German antibody developer MorphoSys.
Resolution: The transaction was cleared by the EU without divestitures, adding a late‑stage oncology asset to Novartis’s portfolio.
The White House has moved to bar Microsoft from sponsoring foreign nationals for U.S. work visas, marking an escalation in immigration enfor...
Meta Platforms Inc., in collaboration with Bret Taylor’s startup Sierra and OpenAI, is working to establish open technical standards aimed a...
Bill Gates, co‑founder of Microsoft and longtime global health philanthropist, publicly rebuked former President Donald Trump for failing to...
The observation that nearly half of the S&P 500's constituents are moving counter to the broader index signals a deepening fragmentation in ...
A growing cohort of consumer‑focused companies are electing to extend their private status, exploiting the rapid maturation of secondary‑mar...